Nurix Therapeutics, Inc. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Nurix Therapeutics, Inc. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2019 to Q1 2025.
  • Nurix Therapeutics, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending February 28, 2025 was $24.2M, a 29.9% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $24.2M -$10.3M -29.9% Feb 28, 2025 10-Q 2025-04-08
Q4 2024 $26.2M -$18.8M -41.8% Nov 30, 2024 10-Q 2025-04-08
Q3 2024 $29.9M +$19.6M +191% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $38.7M +$24M +163% May 31, 2024 10-Q 2024-07-11
Q1 2024 $34.5M +$8.34M +31.9% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $45M +$9.05M +25.2% Nov 30, 2023 10-K 2025-01-28
Q3 2023 $10.2M -$31.3M -75.3% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $14.7M -$31.2M -68% May 31, 2023 10-Q 2023-07-13
Q1 2023 $26.1M -$29.3M -52.9% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $36M -$23M -39.1% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $41.5M -$24.8M -37.4% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $45.9M -$26.3M -36.4% May 31, 2022 10-Q 2022-07-07
Q1 2022 $55.4M -$22.3M -28.7% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $59M -$1.66M -2.74% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $66.4M +$4.01M +6.42% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $72.1M May 31, 2021 10-Q 2021-07-13
Q1 2021 $77.7M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $60.7M +$25M +70% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $62.4M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $35.7M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.